Genetic variation and susceptibility to schizophrenia: Work in progress.

Area of Science:

• Psychiatric Genetics
• Human Genomics
• Pharmacotherapy Development

Background:

• The study initiated in 1990, focusing on schizophrenia genetics when human genome information was limited.
• Advancements in Polymerase Chain Reaction (PCR) and genomic knowledge accelerated research progress.

Purpose of the Study:

• To identify specific genes associated with increased susceptibility to schizophrenia.
• To elucidate the underlying biochemical pathways implicated in schizophrenia.
• To facilitate the development of targeted pharmacotherapies for schizophrenia.

Main Methods:

• Genetic analysis to identify schizophrenia susceptibility genes.
• Biochemical pathway analysis to understand gene function.
• Phenotypic analysis to correlate genetic findings with clinical presentation.

Main Results:

• Progress has been made in identifying genetic factors contributing to schizophrenia.
• The genetic architecture of schizophrenia is complex, involving multiple genes and pathways.

Conclusions:

• While significant strides have been made, further research is necessary to fully understand schizophrenia's genetic basis.
• Continued investigation is essential for translating genetic discoveries into effective pharmacotherapies.